Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera

被引:26
作者
Cario, Holger [1 ]
Schwarz, Klaus [2 ,3 ]
Herter, Jan M. [4 ]
Komrska, Vladimir [5 ,6 ]
McMullin, Mary F. [7 ]
Minkov, Milen [8 ]
Niemeyer, Charlotte [9 ]
Pospisilova, Dagmar [10 ]
Reinhard, Harald [11 ]
Debatin, Klaus-Michael [1 ]
Pahl, Heike L. [4 ]
机构
[1] Univ Hosp Ulm, Dept Paediat, D-89075 Ulm, Germany
[2] Univ Hosp Ulm, Inst Transfus Med, Ulm, Germany
[3] Inst Clin Transfus Med & Immunogenet, Ulm, Germany
[4] Univ Hosp Freiburg, Dept Expt Anaesthesiol, Freiburg, Germany
[5] Charles Univ Prague, Fac Med, Dept Paediat Haematol Oncol, Prague, Czech Republic
[6] Univ Hosp Motol, Prague, Czech Republic
[7] Queens Univ Belfast, Dept Haematol, Belfast City Hosp, Belfast, Antrim, North Ireland
[8] St Anna Childrens Hosp, A-1090 Vienna, Austria
[9] Univ Freiburg, Div Paediat Haematol & Oncol, Dept Paediat & Adolescent Med, Freiburg, Germany
[10] Palacky Univ, Fac Med, Clin Paediat, CR-77147 Olomouc, Czech Republic
[11] Univ Hosp Homburg, Dept Paediat Haematol & Oncol, Homburg, Germany
关键词
polycythemia vera; erythrocytosis; childhood; molecular analysis; Budd-Chiari syndrome;
D O I
10.1111/j.1365-2141.2008.07220.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical, haematological, molecular and treatment data of eight paediatric patients with polycythemia vera (PV) were collected prospectively. One patient developed PV after treatment for large-cell anaplastic lymphoma. Budd-Chiari syndrome was diagnosed in two patients, necessitating orthotopic liver transplantation in one and transjugular portosystemic shunting in the other. The remaining patients presented with non-specific symptoms. Endogenous erythroid colonies were detected in all cases examined. The JAK2(V617F) mutation was found in six patients; two patients displayed JAK2 exon 12 mutations, including one novel mutation (JAK2(H538-K539delinsI)). CD177 (PRV-1) mRNA expression was increased in three of five patients tested.
引用
收藏
页码:622 / 626
页数:5
相关论文
共 13 条
[1]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[2]   Familial polycythemia vera with Budd-Chiari syndrome in childhood [J].
Cario, H ;
Pahl, HL ;
Schwarz, K ;
Galm, C ;
Hoffmann, M ;
Burdelski, M ;
Kohne, E ;
Debatin, KM .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (02) :346-352
[3]  
Cobo F, 1996, MED CLIN-BARCELONA, V107, P660
[4]   PRV-1 mRNA expression discriminates two types of essential thrombocythemia [J].
Griesshammer, M ;
Klippel, S ;
Strunck, E ;
Temerinac, S ;
Mohr, U ;
Heimpel, H ;
Pahl, HL .
ANNALS OF HEMATOLOGY, 2004, 83 (06) :364-370
[5]  
HANN HWL, 1979, CANCER, V43, P1862, DOI 10.1002/1097-0142(197905)43:5<1862::AID-CNCR2820430540>3.0.CO
[6]  
2-K
[7]   Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders [J].
Melear, JM ;
Goldstein, RM ;
Levy, MF ;
Molmenti, EP ;
Cooper, B ;
Netto, GJ ;
Klintmalm, GB ;
Stone, MJ .
TRANSPLANTATION, 2002, 74 (08) :1090-1095
[8]   Stem cell transplantation for polycythemia vera [J].
Reinhard, Herald ;
Klingebiel, Thomas ;
Lang, Peter ;
Bader, Peter ;
Niethammer, Dietrich ;
Graf, Norbert .
PEDIATRIC BLOOD & CANCER, 2008, 50 (01) :124-126
[9]  
ROTH M, 1990, MED KLIN, V85, P529
[10]   JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis [J].
Scott, Linda M. ;
Tong, Wei ;
Levine, Ross L. ;
Scott, Mike A. ;
Beer, Philip A. ;
Stratton, Michael R. ;
Futreal, P. Andrew ;
Erber, Wendy N. ;
McMullin, Mary Frances ;
Harrison, Claire N. ;
Warren, Alan J. ;
Gilliland, D. Gary ;
Lodish, Harvey F. ;
Green, Anthony R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (05) :459-468